Screener
Oric Pharmaceuticals, Inc. ORIC Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $2,895 | $3,824 |
| Accrued liabilities | 14,876 | 16,593 |
| Total current liabilities | 17,771 | 20,417 |
| Other long-term liabilities | 3,434 | 4,111 |
| Total liabilities | 21,205 | 24,528 |
| Commitments and contingencies | ||
| Stockholders' equity: |
Item 1. Financial Statements.
FAQ
- What is Oric Pharmaceuticals, Inc.'s total current liabilities?
- Oric Pharmaceuticals, Inc. (ORIC) reported total current liabilities of $17.77M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s total current liabilities changed year-over-year?
- Oric Pharmaceuticals, Inc.'s total current liabilities increased by 0.9% year-over-year, from $17.62M to $17.77M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s total current liabilities has grown at a 17.8% compound annual growth rate (CAGR), from $9M to $20.42M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Oric Pharmaceuticals, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude